FI782849A7 - Terapeutiska medel - Google Patents

Terapeutiska medel

Info

Publication number
FI782849A7
FI782849A7 FI782849A FI782849A FI782849A7 FI 782849 A7 FI782849 A7 FI 782849A7 FI 782849 A FI782849 A FI 782849A FI 782849 A FI782849 A FI 782849A FI 782849 A7 FI782849 A7 FI 782849A7
Authority
FI
Finland
Prior art keywords
therapeutic medicine
therapeutic
medicine
Prior art date
Application number
FI782849A
Other languages
English (en)
Other versions
FI65246B (fi
FI65246C (fi
Inventor
Peter Frederick Juby
Thomas William Hudyma
Richard Anthony Partyka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI782849A7 publication Critical patent/FI782849A7/fi
Priority to FI824509A priority Critical patent/FI68051C/fi
Publication of FI65246B publication Critical patent/FI65246B/fi
Application granted granted Critical
Publication of FI65246C publication Critical patent/FI65246C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/18Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms
    • C07C331/22Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C331/24Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI782849A 1977-09-21 1978-09-18 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-oxo-4h-pyrimido(2,1-a)isokinolin-3-karboxylsyraderivat FI65246C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI824509A FI68051C (fi) 1977-09-21 1982-12-29 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(1h-tetrazol-5-yl)-4h-pyrimido(2,1-a)isokinolin-4-oner samt farmaceutiskt godtagbara salter av dessa foereningar

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83526677 1977-09-21
US05/835,266 US4127720A (en) 1977-09-21 1977-09-21 Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity

Publications (3)

Publication Number Publication Date
FI782849A7 true FI782849A7 (fi) 1979-03-22
FI65246B FI65246B (fi) 1983-12-30
FI65246C FI65246C (fi) 1984-04-10

Family

ID=25269074

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782849A FI65246C (fi) 1977-09-21 1978-09-18 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-oxo-4h-pyrimido(2,1-a)isokinolin-3-karboxylsyraderivat

Country Status (18)

Country Link
US (1) US4127720A (fi)
JP (1) JPS5463099A (fi)
AU (1) AU522646B2 (fi)
BE (1) BE870634A (fi)
CA (1) CA1108613A (fi)
CH (1) CH642967A5 (fi)
DE (1) DE2841126A1 (fi)
DK (1) DK164553C (fi)
FI (1) FI65246C (fi)
FR (1) FR2404010A1 (fi)
GB (1) GB2004876B (fi)
GR (1) GR72144B (fi)
IE (1) IE47189B1 (fi)
LU (1) LU80272A1 (fi)
NL (1) NL190071C (fi)
SE (1) SE438335B (fi)
YU (2) YU41598B (fi)
ZA (1) ZA785354B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
US4472401A (en) * 1981-11-27 1984-09-18 Roussel Uclaf Pyrimido-quinoxalines having antiallergic properties
GB8331228D0 (en) * 1983-11-23 1983-12-29 Fujisawa Pharmaceutical Co Pyrimidoisoquinoline derivatives
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
US4661592A (en) * 1984-06-27 1987-04-28 G. D. Searle & Co. 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives
AU706110B2 (en) * 1996-04-13 1999-06-10 Astrazeneca Ab Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
RU2394036C2 (ru) * 2004-12-20 2010-07-10 Вайет Аналоги рапамицина и их применение при лечении неврологических, пролиферативных и воспалительных заболеваний
MX2007007409A (es) 2004-12-20 2007-07-12 Wyeth Corp Derivados de rapamicina y los usos de los mismos en el tratamiento de trastornos neurologicos.
US20250296929A1 (en) * 2021-04-04 2025-09-25 Baruch S. Blumberg Institute Novel hepatoselective polyadenylating polymerases inhibitors and their method of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356937A (en) * 1970-08-27 1974-06-19 Wellcome Found Pyrimido-isoquinolines
BE792648A (fr) * 1971-12-13 1973-06-12 May & Baker Ltd Derives de l'isoquinoleine
CA1033731A (en) * 1974-04-01 1978-06-27 Saul B. Kadin Process for preparing 1-oxo-1h-6-hydroxypyrimido (1,2-a)quinoline-2-carboxylic acids and derivatives
US4066766A (en) * 1975-03-03 1978-01-03 Pfizer Inc. 1-Oxo-6-substituted pyrimido [1,2-a]quinoline-2-carboxylic acids and derivatives thereof and their use as antiallergy agents
SU685156A3 (ru) * 1975-08-01 1979-09-05 Пфайзер Инк (Фирма) Способ получени -(5-тетразолил(1-оксо-1н-пиримидо-)1,2-а) хинолин-2-карбоксамида
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4033961A (en) * 1975-10-07 1977-07-05 Warner-Lambert Company Pyrido[2-1-b]quinazolin-ones and their methods of preparation

Also Published As

Publication number Publication date
AU522646B2 (en) 1982-06-17
YU222778A (en) 1984-02-29
DK164553B (da) 1992-07-13
JPS5463099A (en) 1979-05-21
SE438335B (sv) 1985-04-15
NL7809626A (nl) 1979-03-23
DK413578A (da) 1979-03-22
IE47189B1 (en) 1984-01-11
YU63585A (en) 1986-04-30
CA1108613A (en) 1981-09-08
DE2841126C2 (fi) 1990-05-17
FR2404010A1 (fr) 1979-04-20
AU4004278A (en) 1980-03-27
DE2841126A1 (de) 1979-04-05
GB2004876A (en) 1979-04-11
YU41598B (en) 1987-10-31
NL190071B (nl) 1993-05-17
SE7809887L (sv) 1979-03-22
IE781897L (en) 1979-03-21
GB2004876B (en) 1982-03-10
BE870634A (fr) 1979-03-20
LU80272A1 (fr) 1979-06-01
JPS6212225B2 (fi) 1987-03-17
FR2404010B1 (fi) 1980-10-31
ZA785354B (en) 1979-09-26
US4127720A (en) 1978-11-28
FI65246B (fi) 1983-12-30
NL190071C (nl) 1993-10-18
FI65246C (fi) 1984-04-10
CH642967A5 (de) 1984-05-15
YU44501B (en) 1990-08-31
GR72144B (fi) 1983-09-20
DK164553C (da) 1992-11-30

Similar Documents

Publication Publication Date Title
SE7805954L (sv) Terapeutiska medel
FI781613A7 (fi) Terapeutiska hydantoinfoereningar
SE7803527L (sv) Lekemedelsdosenhet
BR7803026A (pt) Penso medicinal
IT1101202B (it) Siringa
DK491877A (da) Sproejte
IS2443A7 (is) thekjuefni til lækninga
DK22978A (da) Laegemiddelsproejte
FI800923A7 (fi) Terapeutiska medel
FI772700A7 (fi) Terapeutiska tandreningsmedel i fodrade behaollare och metoder daerfoer
DK148408C (da) Medicinsk klaebemiddel
SE7807987L (sv) Anti-tumormedel
FI783326A7 (fi) Terapeutiska aemnen
FI782559A7 (fi) Hudvaordsmedel
SE7601894L (sv) Terapeutiskt medel
FI824098A0 (fi) Terapeutiskt medel
FI783335A7 (fi) Behandlingshuvud foer elektromedicinsk diagnostisk eller terapeutisk behandling av kroppsdelar
FI780738A7 (fi) Framstaellning av terapeutiska medel
FI782849A7 (fi) Terapeutiska medel
SE7806441L (sv) Lekemedelskomposition
FI780350A7 (fi) Nya terapeutiska medel
SE7812198L (sv) Antitumormedel
FI803221L (fi) Terapeutiskt anvaendbara pyridinderivat
FI801929A7 (fi) Terapeutiska pyridylaminotriazolaemnen
FI780433A7 (fi) Antimikrobiella medel

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS CO